HPV immunization coverage estimates among primary target cohort (9-14) in Upper-middle income (World Bank)
Upper-middle income (World Bank): HPV immunization coverage estimates among primary target cohort (9-14) was 32.0% in 2025. ◆ Volatile
HPV immunization coverage estimates among primary target cohort (9-14) in Upper-middle income (World Bank), 2010–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Upper-middle income (World Bank) recorded 32.0% for hpv immunization coverage estimates among primary target cohort (9-14) in 2025. That is the highest value across all 16 years on record.
The figure is up 3.2% on the previous year and up 68.4% over ten years.
Over the whole period, hpv immunization coverage estimates among primary target cohort (9-14) in Upper-middle income (World Bank) peaked at 32.0% in 2025 and was at its lowest, 1.0%, in 2010.
The series is highly variable year to year, so single readings are best treated with caution.
HPV immunization coverage estimates among primary target cohort (9-14) in Upper-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 1.0% | — |
| 2011 | 3.0% | +200.0% |
| 2012 | 7.0% | +133.3% |
| 2013 | 8.0% | +14.3% |
| 2014 | 19.0% | +137.5% |
| 2015 | 19.0% | +0.0% |
| 2016 | 20.0% | +5.3% |
| 2017 | 23.0% | +15.0% |
| 2018 | 22.0% | -4.3% |
| 2019 | 18.0% | -18.2% |
| 2020 | 15.0% | -16.7% |
| 2021 | 13.0% | -13.3% |
| 2022 | 20.0% | +53.8% |
| 2023 | 29.0% | +45.0% |
| 2024 | 31.0% | +6.9% |
| 2025 | 32.0% | +3.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 14.0% | 1.0% | 23.0% | 10 |
| 2020s | 23.3% | 13.0% | 32.0% | 6 |
Countries ranked near Upper-middle income (World Bank)
- 4 Bhutan 98.0% compare
- 5 Portugal 97.0% compare
- 5 Sao Tome and Principe 97.0% compare
- 7 Sri Lanka 96.0% compare
- 7 Lao People's Democratic Republic 96.0% compare
- 9 Malta 95.0% compare
- 9 Turkmenistan 95.0% compare
More health data for Upper-middle income (World Bank)
- Pertussis - number of reported cases, gaps filled 63,803 (2025)
- Total tetanus - number of reported cases, gaps filled 5,773 (2025)
- Diphtheria - number of reported cases, gaps filled 1,556 (2025)
- Measles - number of reported cases, gaps filled 91,627 (2025)
- Measles - number of reported cases, annual growth rate -27.52 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -87.69 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 10.32 % change on previous year (2025)
- Diphtheria - number of reported cases 1,556 (2025)
- Total tetanus - number of reported cases 5,773 (2025)
- Pertussis - number of reported cases 63,803 (2025)
Frequently asked questions
- What is hpv immunization coverage estimates among primary target cohort (9-14) in Upper-middle income (World Bank)?
- Hpv immunization coverage estimates among primary target cohort (9-14) in Upper-middle income (World Bank) was 32.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest hpv immunization coverage estimates among primary target cohort (9-14) recorded in Upper-middle income (World Bank)?
- The highest recorded value was 32.0% in 2025.
- What is the lowest hpv immunization coverage estimates among primary target cohort (9-14) recorded in Upper-middle income (World Bank)?
- The lowest recorded value was 1.0% in 2010.
- How does Upper-middle income (World Bank) rank for hpv immunization coverage estimates among primary target cohort (9-14)?
- Upper-middle income (World Bank) ranks 6th out of 11 groups with data for 2025.
- Is hpv immunization coverage estimates among primary target cohort (9-14) rising or falling in Upper-middle income (World Bank)?
- Over the last ten years it is up 68.4%. The long-run trend across the full record is volatile.
- Where does this Upper-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).